Attention Michigan Residents, Check Your ADHD Meds For A Recall

Michigan residents who take a particular ADHD medicine will want to consult with their physician after a massive recall has been put into effect nationwide at the end of October

The Food and Drug Administration has issued the recall for a medication that was shipped by Sun Pharmaceutical Industries between May 1, 2024, and November 13, 2024, with an expiration date of 2026:

ADHD Medicine Being Recalled

Lisdexamfetamine Dimesylate Capsules, 10 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901.

This medication is a generic form of the drug Vyvanse.

Reason For Recall

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.

In so many words, the reason the medication is being recalled is because it's not working as it should be, according to the Board of Pharmacy, as they detailed in their statement:

Dissolution is important for drugs to be absorbed and have a physiological effect on the human body, they must be in solution. The impacted capsules would not be able to deliver an optimal level of medicine and may impact the therapeutic efficacy of the product.

The good news is that those who take the medication can continue to take it if necessary without the worry of adverse effects, as they pointed out. It just seems kind of important that the medicine you're taking is actually working, so a refund or exchange is suggested for those with the medication.